{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigfcuprai75egsqar3qrcfkcbowrusnw7vmql2ax4d6etoqnlt7be",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhqwfxo7ojh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigg6hia6cis45azvwe2ec7avdliepig3mwcrqhwrlxaulivpl3k2i"
    },
    "mimeType": "image/jpeg",
    "size": 275628
  },
  "path": "/news/2026-03-term-lung-persist-tuberculosis-treatment.html",
  "publishedAt": "2026-03-23T15:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections. Scientists at A*STAR Infectious Diseases Labs (A*STAR IDL) have recently uncovered how structures formed in the lungs during TB infection, known as tuberculous granulomas, can create conditions that allow secondary lung infections to take hold.",
  "title": "Why long-term lung risks persist after tuberculosis treatment"
}